全文获取类型
收费全文 | 366篇 |
免费 | 28篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 8篇 |
妇产科学 | 33篇 |
基础医学 | 26篇 |
口腔科学 | 3篇 |
临床医学 | 68篇 |
内科学 | 84篇 |
皮肤病学 | 4篇 |
神经病学 | 24篇 |
特种医学 | 7篇 |
外科学 | 34篇 |
综合类 | 5篇 |
预防医学 | 25篇 |
眼科学 | 7篇 |
药学 | 43篇 |
中国医学 | 1篇 |
肿瘤学 | 15篇 |
出版年
2024年 | 1篇 |
2023年 | 7篇 |
2022年 | 7篇 |
2021年 | 23篇 |
2020年 | 14篇 |
2019年 | 16篇 |
2018年 | 11篇 |
2017年 | 18篇 |
2016年 | 21篇 |
2015年 | 19篇 |
2014年 | 22篇 |
2013年 | 21篇 |
2012年 | 28篇 |
2011年 | 35篇 |
2010年 | 19篇 |
2009年 | 12篇 |
2008年 | 18篇 |
2007年 | 16篇 |
2006年 | 19篇 |
2005年 | 18篇 |
2004年 | 13篇 |
2003年 | 18篇 |
2002年 | 10篇 |
2000年 | 2篇 |
1999年 | 1篇 |
1998年 | 4篇 |
1996年 | 2篇 |
1995年 | 1篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1991年 | 1篇 |
排序方式: 共有399条查询结果,搜索用时 15 毫秒
101.
Galanin is a potent in vivo modulator of mesencephalic serotonergic neurotransmission. 总被引:4,自引:0,他引:4
Jan Kehr Takashi Yoshitake Fu-Hua Wang Haleh Razani Lydia Gimenez-Llort Anders Jansson Masatoshi Yamaguchi Sven Ove Ogren 《Neuropsychopharmacology》2002,27(3):341-356
Neurochemical, molecular, immunohistochemical and behavioral methods were used to examine the in vivo effects of the neuropeptide galanin on central 5-HT neurotransmission and on 5-HT(1A) receptor-mediated responses. Intraventricularly infused galanin caused a long-lasting and dose-dependent reduction of basal extracellular 5-HT levels in the ventral hippocampus of awake rats as measured by microdialysis. Infusion of galanin into the dorsal raphe nucleus (DRN), but not intra-hippocampally, reduced 5-HT release. The effect of i.c.v. galanin on 5-HT release was blocked by the galanin receptor antagonist M35, acting most likely via galanin receptors at the level of the DRN. Galanin also reduced the levels of tryptophanhydroxylase mRNA in the DRN. Therefore, the effects of galanin on 5-HT(1A) receptor-mediated responses were further investigated. Surprisingly, galanin significantly attenuated the reduction of hippocampal 5-HT release induced by systemic injection of the 5-HT(1A) receptor agonist 8-OH-DPAT. Galanin also attenuated 8-OH-DPAT-induced hypothermia and locomotor activity in rats. These results indicate that galanin has important inhibitory actions on central 5-HT neurotransmission and on 5-HT(1A) receptor-mediated events. 相似文献
102.
103.
Disparities in contraceptive knowledge, attitude and use between Hispanic and non-Hispanic whites 总被引:2,自引:0,他引:2
BACKGROUND: Higher rates of unwanted pregnancies and lower rates of contraceptive use have been reported among Hispanic women than among non-Hispanic whites. Despite these differences, it is unclear how these groups differ with respect to various psychosocial factors that are associated with contraceptive decision making, including contraceptive knowledge, attitudes, self-efficacy and social support. METHODS: A total of 443 sexually active, nonpregnant, low-income women (137 non-Hispanic whites, 74 US-born Hispanics and 231 non-US-born Hispanics) were surveyed at two publicly funded clinics. RESULTS: The greatest number of barriers to the effective use of contraception was seen among non-US-born Hispanic women. Fewer differences emerged between US-born Hispanics and whites, although differences continued to exist between the two groups in certain key areas. As compared to non-Hispanic whites, US-born Hispanic women had lower levels of social support for and self-efficacy in contraceptive use, desired larger families, had more religious objections to using birth control and were more those likely to believe that birth control use is the responsibility of women. As compared to whites, both US and non-US-born Hispanic women had significantly lower rates of ever-use of contraceptives that are highly effective in preventing pregnancy or in preventing disease transmission, and higher rates of unintended pregnancies. All associations were independent of known confounders. CONCLUSION: Despite improvements in contraceptive knowledge and attitude, birth control and disease-preventive practices did not improve significantly among Hispanics who were born in the United States. Hispanic women are at higher risk for unintended pregnancy than are non-Hispanic whites, irrespective of their US nativity. 相似文献
104.
105.
106.
107.
Can drugs induce or aggravate sleep apneas? A case–noncase study in VigiBase®, the WHO pharmacovigilance database 下载免费PDF全文
Mélanie Linselle Agnès Sommet Emmanuelle Bondon‐Guitton Florence Moulis Geneviève Durrieu Justine Benevent Vanessa Rousseau Leila Chebane Haleh Bagheri François Montastruc Jean‐Louis Montastruc 《Fundamental & clinical pharmacology》2017,31(3):359-366
The potential favorizing role of drugs in sleep apnea syndrome (SAS) is unknown. This study investigates drugs associated with SAS in a pharmacovigilance database. SAS recorded as adverse drug reactions (ADRs) in VigiBase®, the WHO pharmacovigilance database (more than 11 million reports), from 1978 to 2015 was selected. The risk of SAS reports was estimated using the case–noncase method, with cases being SAS and noncases all other recorded ADRs. During this 37‐year period, 3325 ADRs including the word SAS were registered (0.05% of the database). Mean age was 51.2 ± 16.9 years with 52% men. ADRs were ‘serious’ in around 82% of cases. The case–noncase study found an association between SAS and exposition with sodium oxybate, rofecoxib, quetiapine, and clozapine for individual drugs and coxibs, antipsychotics, benzodiazepines, and opium alkaloids for drug classes. The potential role of other drugs is discussed. This study suggests that SAS can be associated with some drugs (mainly psychotropics) that are able to reveal or aggravate such a disease. Physicians should take into account the role of drugs in the etiological appraisal and management of SAS. 相似文献
108.
109.